The National Sales Perspectives (NSP) service provides a U.S.-based national view of estimated pharmaceutical sales, including sell-in sales to retail and non-retail outlets and sell-out sales from reporting mail service pharmacies. NSP uses actual invoice prices from reporting suppliers and applies Weighted Average Price (WAP) when invoice prices are unavailable, creating a consistent view of market activity. NSP is the U.S. sales standard that contributes to IQVIA's global MIDAS solution.

Designed for pharmaceutical manufacturers, financial institutions, consultants, academic organizations, and other healthcare stakeholders, NSP combines reported direct sales and projected indirect sales to estimate total U.S. pharmaceutical sales across retail, non-retail, and mail channels. By integrating distributor, manufacturer, and pharmacy sales data, NSP helps organizations monitor market performance, assess product trends, and support commercial planning and forecasting.

Download the brochure to learn how NSP delivers a consistent national view of pharmaceutical sales through invoice-based pricing, projected distributor sales, and integrated channel insights to support market analysis and strategic decision-making.